27 NOV Published on November 27, 2024 by pharmaffiliates Understanding Elobixibat: A New Chapter In The Fight Against Chronic Constipation In recent years, there has been a surge of interest in finding effective treatments for chronic constipation and irritable bowel syndrome with constipation (IBS-C)—two conditions that affect millions of people worldwide. Read More
16 October Published on October 16, 2024 by pharmaffiliates Breakthrough in Brain Tumor Research-VORTIOXETINE Recent advancements in brain tumor research have illuminated the potential of VORTIOXETINE a well-known antidepressant, in the context of neuro-oncology. Read More
11 October Published on October 11, 2024 by pharmaffiliates Get ready to connect and innovate! đź“… Join us at CPHI INDIA 2024! We are thrilled to announce that Pharmaffiliates will be participating in the esteemed CPHI India 2024 Exhibition! This renowned international event serves as a premier platform for innovation, networking and collaboration among industry leaders in the pharmaceutical sector. Read More
16 SEP Published on September 16, 2024 by pharmaffiliates Mark your calendars!! Delighted to announce our participation at CPHI, Milan 2024 We're excited to announce that Pharmaffiliates will be participating in the prestigious CPHI, Milan 2024 Exhibition! This international event is a hub for innovation, networking, and industry leaders. Read More
06 August Published on August06, 2024 by pharmaffiliates Pharmaffiliates is Exhibiting at Arablab 2024! Pharmaffiliates is thrilled to announce our participation at the prestigious Arab Lab 2024, taking place at the Dubai World Trade Centre from September 24th to 26th. Read More
08-10 September Published on September08-10, 2024 by pharmaffiliates Excited to announce our participation at Pharmaconex CPHI Egypt! Pharmaffiliates is thrilled to announce our participation at the Pharmaconex CPHI Egypt, taking place at the Egypt International Exhibition Center in Cairo, Egypt from September 08-10, 2024. Read More
04 January Published on January04, 2022 by pharmaffiliates Desperate hunt of Anti-Virals for COVID-19 cure It is rightly said 'Desperate Times Call for Desperate Measures' As cases from the coronavirusare relentlessly mounting into hundreds and thousands again Read More
24 August Published on August24, 2021 by pharmaffiliates Pharmaffiliates - A Perfect Outsourcing Partner CRAMS or Contract Research and Manufacturing Services, which is the newest, fastest growing and the most sought after segment in Pharmaceutical world. Read More
24 July Published on July24, 2021 by pharmaffiliates Pharmaffiliates - Leading the way for Research Stable isotope labeling includes the use of non-radioactive isotopes which can serve as tracers that are used to track different ..... Read More
18 Sep Published on Sep18, 2020 by pharmaffiliates Tenofovir - A Wonder Drug For Covid -19 As the coronavirus pandemic swept through major part of the world in 2020, the US Food and Drug Administration has approved antiviral ..... Read More
7 Aug Published on Aug7, 2020 by pharmaffiliates Quetiapine - Atypical Antipsychotic Drug An atypical antipsychotic, Quetiapine is a dibenzothiazepine derivative which is available in different pharmaceutical forms. ..... Read More
17 Jun Published on Jun17, 2020 by pharmaffiliates Lopinavir/Ritonavir- A promising co-formulated drug End of December 2019 and beginning of the year 2020 marked the emergence of, a novel coronavirus, designated SARS-CoV-2, and has caused an international ..... Read More
02 Jun Published on Jun 02, 2020 by pharmaffiliates Remdesivir – A new “standard of care” against COVID 19 Fauci, the director of the National Institute of Allergy and Infectious Diseases, announced in an unpublished from a phase 3 trial that showed Remdesivir ..... Read More
01 April Published on April 01, 2020 by pharmaffiliates Chloroquine And Hydroxychloroquine - A Ray Of Hope It is evident; there are no specific drugs for COVID-19. Scientists and researchers around the globe are leaving no stone unturned to find a cure for..... Read More
04 March Published on March 04, 2020 by pharmaffiliates Ondansetron- A Globally Accepted Antiemetic Drug A recent report by Medspace suggests that Acute Gastroenteritis is responsible for some 600,000 hospitalizations and 5000 deaths a year in the..... Read More
22 Feb Published on Feb 22, 2020 by pharmaffiliates Olmesartan – A NDMA Free Drug Declared By FDA Over 350 million people in the world currently are suffering from Diabetes mellitus (DM) which is a major metabolic disorder that is prevalent in both developed and developing..... Read More
13 Feb Published on Feb 13, 2020 by pharmaffiliates CORONAVIRUS (2019-nCoV) TREATMENT-ATAZANAVIR a Ray of Hope For centuries, the world has time and again come under the grip of epidemics which wipe out a major portion of civilization. And by the time scientific and medicinal fraternity ..... Read More
